Published in:
Open Access
01-06-2010 | Editorial
Should mechanical dyssynchrony be assessed in patients with implantable cardioverter-defibrillators?
Authors:
Mark J. Boogers, MD, Martin J. Schalij, MD, PhD, Jeroen J. Bax, MD, PhD
Published in:
Journal of Nuclear Cardiology
|
Issue 3/2010
Login to get access
Excerpt
Implantable cardioverter-defibrillator (ICD) therapy represents a cornerstone treatment in patients at risk for sudden cardiac death.
1,
2 Indications for ICD therapy have evolved considerably from survivors of sustained ventricular tachycardia or ventricular fibrillation to patients with depressed left ventricular (LV) systolic function (LV ejection fraction (LVEF) < 30-40%), regardless of prior ventricular tachyarrhythmias.
3-
8 …